Citius Pharmaceuticals, Inc.
CTXR- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001506251
No open-market purchases or sales by Citius Pharmaceuticals, Inc. insiders were filed in the last 90 days; 42 institutions reported holding it in 13F filings for Q2 2026, worth $822.4K in total; no superinvestor holds it.
Q2 2026 vs. Q1 2026
How the institutions holding Citius Pharmaceuticals, Inc. changed between Q1 2026 and Q2 2026.
All holders in Q2 2026All holders in Q1 2026
| Measure | Q1 2026 | Q2 2026 | Change |
|---|---|---|---|
| Holders | 38 | 42 | +4 |
| Shares | 996.9K | 1.36M | +362.6K (+36.4%) |
| Value | $896.9K | $822.4K | −$74.5K (−8.3%) |
New holders (12)
Institutions that held Citius Pharmaceuticals, Inc. at the end of Q2 2026 but not at the end of Q1 2026.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Citadel Advisors LLC | 124,910 | $75.5K | 0.00% |
| BostonPremier Wealth LLC | 28,000 | $16.9K | 0.01% |
| Virtu Financial LLC | 20,836 | $13.0K | 0.00% |
| Sanctuary Advisors, LLC | 11,810 | $7.14K | 0.00% |
| R Squared Ltd | 11,033 | $6.67K | 0.00% |
| Two Sigma Securities, LLC | 10,006 | $6.05K | 0.00% |
| Group One Trading, L.P. | 1,551 | $938 | 0.00% |
| Simplex Trading, LLC | 1,256 | $759 | 0.00% |
| Barclays PLC | 1,096 | $663 | 0.00% |
| Wells Fargo & Company | 1,000 | $605 | 0.00% |
| Luminist Capital LLC | 435 | $263 | 0.00% |
| SRS Capital Advisors, Inc. | 84 | $51 | 0.00% |
Sold out (8)
Institutions that held Citius Pharmaceuticals, Inc. at the end of Q1 2026 and filed for Q2 2026 without it.
| Institution | Shares, Q1 2026 | Value, Q1 2026 |
|---|---|---|
| HRT Financial LP | 60,332 | $54.0K |
| Citigroup Inc | 5,228 | $4.71K |
| Curio Wealth, LLC | 2,000 | $1.80K |
| Vanguard Global Advisers, LLC | 1,788 | $1.61K |
| Ameritas Advisory Services, LLC | 1,000 | $900 |
| GWM Advisors LLC | 400 | $360 |
| Murphy & Mullick Capital Management Corp | 160 | $144 |
| Northwestern Mutual Wealth Management Co | 8 | $8 |